Dentsply Sirona Inc (XRAY)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 1,796,000 1,803,000 1,841,000 1,842,000 1,826,000 1,737,000 1,807,000 1,872,000 1,913,000 1,925,000 1,946,000 1,923,000 1,978,000 1,930,000 2,182,700 1,421,200 1,433,000 1,403,900 1,441,300 1,545,100
Total stockholders’ equity US$ in thousands 3,293,000 3,375,000 3,706,000 3,641,000 3,811,000 3,613,000 4,837,000 4,863,000 4,996,000 5,060,000 5,074,000 4,927,000 4,932,000 4,760,500 4,643,100 4,687,500 5,093,000 5,057,300 5,181,100 5,107,700
Debt-to-capital ratio 0.35 0.35 0.33 0.34 0.32 0.32 0.27 0.28 0.28 0.28 0.28 0.28 0.29 0.29 0.32 0.23 0.22 0.22 0.22 0.23

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $1,796,000K ÷ ($1,796,000K + $3,293,000K)
= 0.35

The debt-to-capital ratio of DENTSPLY Sirona Inc has shown relatively stable trends over the past eight quarters, ranging from 0.30 to 0.39. This ratio measures the proportion of the company's capital that is financed by debt, with a higher ratio indicating a larger reliance on debt funding.

In the most recent quarter, Q4 2023, the debt-to-capital ratio was 0.39, which is slightly higher compared to the previous quarter and the highest level over the past two years. This suggests a slight increase in the company's debt relative to its total capital in Q4 2023.

Overall, the company's debt-to-capital ratio has fluctuated within a relatively narrow range, indicating a balance between debt and equity in the company's capital structure. It's important for investors to monitor changes in this ratio over time to assess the company's financial risk and leverage levels.


Peer comparison

Dec 31, 2023

Company name
Symbol
Debt-to-capital ratio
Dentsply Sirona Inc
XRAY
0.35
Envista Holdings Corp
NVST
0.25